TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer.

M Dror Michaelson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.